302 related articles for article (PubMed ID: 15764699)
1. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor.
Sanchez T; Thangada S; Wu MT; Kontos CD; Wu D; Wu H; Hla T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4312-7. PubMed ID: 15764699
[TBL] [Abstract][Full Text] [Related]
2. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN.
Sanchez T; Skoura A; Wu MT; Casserly B; Harrington EO; Hla T
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1312-8. PubMed ID: 17431187
[TBL] [Abstract][Full Text] [Related]
3. The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration.
Lepley D; Paik JH; Hla T; Ferrer F
Cancer Res; 2005 May; 65(9):3788-95. PubMed ID: 15867375
[TBL] [Abstract][Full Text] [Related]
4. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.
Lu Y; Yu Q; Liu JH; Zhang J; Wang H; Koul D; McMurray JS; Fang X; Yung WK; Siminovitch KA; Mills GB
J Biol Chem; 2003 Oct; 278(41):40057-66. PubMed ID: 12869565
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN.
Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A
Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311
[TBL] [Abstract][Full Text] [Related]
6. Regulation of PTEN by Rho small GTPases.
Li Z; Dong X; Wang Z; Liu W; Deng N; Ding Y; Tang L; Hla T; Zeng R; Li L; Wu D
Nat Cell Biol; 2005 Apr; 7(4):399-404. PubMed ID: 15793569
[TBL] [Abstract][Full Text] [Related]
7. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease.
Wishart MJ; Dixon JE
Trends Cell Biol; 2002 Dec; 12(12):579-85. PubMed ID: 12495846
[TBL] [Abstract][Full Text] [Related]
8. Pten signaling in gliomas.
Knobbe CB; Merlo A; Reifenberger G
Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
[TBL] [Abstract][Full Text] [Related]
9. S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN.
Malchinkhuu E; Sato K; Maehama T; Mogi C; Tomura H; Ishiuchi S; Yoshimoto Y; Kurose H; Okajima F
Biochem Biophys Res Commun; 2008 Feb; 366(4):963-8. PubMed ID: 18088600
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis. Involvement of G(ialpha2)-linked Rho kinase activity.
Liu F; Verin AD; Wang P; Day R; Wersto RP; Chrest FJ; English DK; Garcia JG
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):711-9. PubMed ID: 11415936
[TBL] [Abstract][Full Text] [Related]
11. Roles of PDK-1 and PKN in regulating cell migration and cortical actin formation of PTEN-knockout cells.
Lim MA; Yang L; Zheng Y; Wu H; Dong LQ; Liu F
Oncogene; 2004 Dec; 23(58):9348-58. PubMed ID: 15531926
[TBL] [Abstract][Full Text] [Related]
12. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis.
Del Galdo S; Vettel C; Heringdorf DM; Wieland T
Cell Signal; 2013 Dec; 25(12):2478-84. PubMed ID: 23993968
[TBL] [Abstract][Full Text] [Related]
13. Rho Rocks PTEN.
Meili R; Sasaki AT; Firtel RA
Nat Cell Biol; 2005 Apr; 7(4):334-5. PubMed ID: 15803130
[No Abstract] [Full Text] [Related]
14. PTEN gene and integrin signaling in cancer.
Tamura M; Gu J; Tran H; Yamada KM
J Natl Cancer Inst; 1999 Nov; 91(21):1820-8. PubMed ID: 10547389
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity.
White ES; Atrasz RG; Dickie EG; Aronoff DM; Stambolic V; Mak TW; Moore BB; Peters-Golden M
Am J Respir Cell Mol Biol; 2005 Feb; 32(2):135-41. PubMed ID: 15539459
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.
Tamura M; Gu J; Matsumoto K; Aota S; Parsons R; Yamada KM
Science; 1998 Jun; 280(5369):1614-7. PubMed ID: 9616126
[TBL] [Abstract][Full Text] [Related]
17. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
[TBL] [Abstract][Full Text] [Related]
18. Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors.
Kwon J; Lee SR; Yang KS; Ahn Y; Kim YJ; Stadtman ER; Rhee SG
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16419-24. PubMed ID: 15534200
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic action of (2S,3S,4R)-N"-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine (KR-31378) by suppression of the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation and increased phosphorylation of casein kinase2/Akt/ cyclic AMP response element binding protein via maxi-K channel opening in neuronal cells.
Kim KY; Lee JH; Park JH; Yoo MA; Kwak YG; Kim SO; Yoo SE; Hong KW
Eur J Pharmacol; 2004 Aug; 497(3):267-77. PubMed ID: 15336944
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.
Balthasar S; Samulin J; Ahlgren H; Bergelin N; Lundqvist M; Toescu EC; Eggo MC; Törnquist K
Biochem J; 2006 Sep; 398(3):547-56. PubMed ID: 16753042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
